Chondroitin

Clinical Studies

Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodies.

Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women.

Versican mediates mesenchymal-epithelial transition.

The use of artificial dermis in the treatment of chronic and acute wounds: regeneration of dermis and wound healing.

The effects of chondroitin sulfate supplementation on indices of muscle damage induced by eccentric arm exercise.

Versican G3 domain promotes blood coagulation through suppressing the activity of tissue factor pathway inhibitor-1.

Plasmodium falciparum: chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta.

Medical treatment of osteoarthritis in the horse - a review.

Mammalian expression of full-length bovine aggrecan and link protein: formation of recombinant proteoglycan aggregates and analysis of proteolytic cleavage by ADAMTS-4 and MMP-13.

The involvement of aggrecan polymorphism in degeneration of human intervertebral disc and articular cartilage.

Effects of low molecular weight heparin in obstructed kidneys: decrease of collagen, fibronectin and TGF-beta, and increase of chondroitin/dermatan sulfate proteoglycans and macrophage infiltration.

A chondroitin sulfate chain attached to the bone dentin matrix protein 1 NH2-terminal fragment.

Immunohistochemical labelling of components of the endoneurial extracellular matrix of intact and rhizotomized dorsal and ventral spinal roots of the rat--a quantitative evaluation using image analysis.

New classification of ophthalmic viscosurgical devices--2005.

The brachymorph mouse and the developmental-genetic basis for canalization and morphological integration.

Regulation of high molecular weight-melanoma associated antigen (HMW-MAA) gene expression by promoter DNA methylation in human melanoma cells.

Supplemental conditionally essential nutrients in cardiovascular disease therapy.

Regeneration of lesioned entorhino-hippocampal axons in vitro by combined degradation of inhibitory proteoglycans and blockade of Nogo-66/NgR signaling.

[Combined medication ARTRA in the treatment of osteoarthrosis]

DNA based customized nutraceutical "gene therapy" utilizing a genoscore: a hypothesized paradigm shift of a novel approach to the diagnosis, stratification, prognosis and treatment of inflammatory processes in the human.

Page 7 of 25

[<< Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 [Next >>]

Back To Categories

We are strictly a bulk supplier to manufacturers – we do not sell to re-sellers or individuals. Our minimum order size is approximately 25 kilos. We are one of only a few suppliers that carry $5 million product liability insurance for our customers. AHD International LLC is classified as a importer, exporter, manufacturer, distributor of nutritional ingredients depending on the ingredient specified. AHD has 5 warehouse locations across North America and sales agents in over 10 countries. We are the only ingredient company to be awarded the Dun and Bradstreet's fastest growing company in America twice in 1999 and 2002..

For quotes please click here

*"These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."